Literature DB >> 10752572

Motor unit changes in sporadic idiopathic Parkinson's disease.

J N Caviness1, B E Smith, J C Stevens, C H Adler, R J Caselli, C A Reiners, J G Hentz, M D Muenter.   

Abstract

We studied motor unit changes in 20 patients with Parkinson's disease (PD) and 20 age-matched control subjects to look for evidence of motorneuron degeneration in sporadic idiopathic PD. Patients and control subjects were screened by clinical criteria and nerve conduction studies to exclude those with peripheral neuropathic processes. Changes in motor unit morphology were investigated with subjective and computerized quantitative electromyography (QEMG) of the anterior tibialis (AT) and first dorsal interosseous. Multivariate comparisons showed a significant difference in the QEMG analysis for motor unit enlargement in patients with PD versus control subjects. Some of the univariate comparisons for both the subjective and QEMG analyses of the AT were also significant. These results demonstrate that motorneuron drop-out with reinnervation occurs in sporadic idiopathic PD. In summary, our findings provide evidence that clinically silent motorneuron disease occurs in typical cases of sporadic idiopathic PD, suggesting that it may be a normal part of the pathologic picture of PD. Any hypothesis concerning the pathogenic mechanism of PD would need to take into account such a finding.

Entities:  

Mesh:

Year:  2000        PMID: 10752572     DOI: 10.1002/1531-8257(200003)15:2<238::aid-mds1006>3.0.co;2-j

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  8 in total

Review 1.  How to diagnose MSA early: the role of sphincter EMG.

Authors:  D B Vodusek
Journal:  J Neural Transm (Vienna)       Date:  2005-12       Impact factor: 3.575

2.  Effects of aging and Parkinson's disease on motor unit remodeling: influence of resistance exercise training.

Authors:  Neil A Kelly; Kelley G Hammond; C Scott Bickel; Samuel T Windham; S Craig Tuggle; Marcas M Bamman
Journal:  J Appl Physiol (1985)       Date:  2017-12-21

3.  Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders.

Authors:  Thomas G Beach; Charles H Adler; Lucia I Sue; Linda Vedders; Lihfen Lue; Charles L White Iii; Haru Akiyama; John N Caviness; Holly A Shill; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2010-03-21       Impact factor: 17.088

4.  Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease.

Authors:  Liancai Mu; Stanislaw Sobotka; Jingming Chen; Hungxi Su; Ira Sanders; Charles H Adler; Holly A Shill; John N Caviness; Johan E Samanta; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2013-02       Impact factor: 3.685

5.  Altered pharyngeal muscles in Parkinson disease.

Authors:  Liancai Mu; Stanislaw Sobotka; Jingming Chen; Hungxi Su; Ira Sanders; Charles H Adler; Holly A Shill; John N Caviness; Johan E Samanta; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2012-06       Impact factor: 3.685

6.  Skeletal muscle transcriptional networks linked to type I myofiber grouping in Parkinson's disease.

Authors:  Kaleen M Lavin; Stuart C Sealfon; Merry-Lynn N McDonald; Brandon M Roberts; Katarzyna Wilk; Venugopalan D Nair; Yongchao Ge; Preeti Lakshman Kumar; Samuel T Windham; Marcas M Bamman
Journal:  J Appl Physiol (1985)       Date:  2019-12-12

7.  Distribution of α-synuclein in the spinal cord and dorsal root ganglia in an autopsy cohort of elderly persons.

Authors:  Hiroyuki Sumikura; Masaki Takao; Hiroyuki Hatsuta; Shinji Ito; Yuta Nakano; Akiko Uchino; Akane Nogami; Yuko Saito; Hideki Mochizuki; Shigeo Murayama
Journal:  Acta Neuropathol Commun       Date:  2015-09-15       Impact factor: 7.801

Review 8.  Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?

Authors:  Bradley Roberts; Frances Theunissen; Francis L Mastaglia; P Anthony Akkari; Loren L Flynn
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.